These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6577012)

  • 1. Morphological changes in osteosarcoma after chemotherapy--COSS 80.
    Delling G; Krumme H; Salzer-Kuntschik M
    J Cancer Res Clin Oncol; 1983; 106 Suppl():32-7. PubMed ID: 6577012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80.
    Salzer-Kuntschik M; Delling G; Beron G; Sigmund R
    J Cancer Res Clin Oncol; 1983; 106 Suppl():21-4. PubMed ID: 6577010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas.
    Uhl M; Saueressig U; Koehler G; Kontny U; Niemeyer C; Reichardt W; Ilyasof K; Bley T; Langer M
    Pediatr Radiol; 2006 Dec; 36(12):1306-11. PubMed ID: 17031633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear polymorphism in osteosarcomas as a prognostic factor for the effect of chemotherapy. A quantitative study.
    Apel R; Delling G; Krumme H; Winkler K; Salzer-Kuntschik M
    Virchows Arch A Pathol Anat Histopathol; 1985; 405(2):215-23. PubMed ID: 3918386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
    Schulte M; Brecht-Krauss D; Werner M; Hartwig E; Sarkar MR; Keppler P; Kotzerke J; Guhlmann A; Delling G; Reske SN
    J Nucl Med; 1999 Oct; 40(10):1637-43. PubMed ID: 10520703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
    Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
    Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy-induced changes in osteosarcoma after neoadjuvant chemotherapy (COSS 86 Therapy Study). Correlation between morphologic findings and clinical follow-up].
    Werner M; Fuchs N; Salzer-Kuntschik M; Winkler K; Delling G
    Pathologe; 1996 Jan; 17(1):35-43. PubMed ID: 8685094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis.
    Franzius C; Sciuk J; Brinkschmidt C; Jürgens H; Schober O
    Clin Nucl Med; 2000 Nov; 25(11):874-81. PubMed ID: 11079583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteogenic progenitor cell potency after high-dose chemotherapy (COSS-96).
    Jäger M; Schultheis A; Westhoff B; Krauspe R
    Anticancer Res; 2005; 25(2A):947-54. PubMed ID: 15868932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytostatic effects in osteosarcomas as detected by flow cytometric DNA analysis after preoperative chemotherapy according to the COSS 80/82 protocol.
    Bösing T; Roessner A; Hiddemann W; Mellin W; Grundmann E
    J Cancer Res Clin Oncol; 1987; 113(4):369-75. PubMed ID: 3474234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological investigation of tumor growth and distribution of viable tumour areas in osteosarcomas after chemotherapy.
    Delling G; Pompesius-Kempa M; Welkerling H; Dreyer T; Maas R; Heise U; Winkler K
    Chir Organi Mov; 1990; 75(1 Suppl):45-7. PubMed ID: 2249555
    [No Abstract]   [Full Text] [Related]  

  • 13. Heat shock protein 72 expression in osteosarcomas correlates with good response to neoadjuvant chemotherapy.
    Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
    Hum Pathol; 1998 Oct; 29(10):1050-5. PubMed ID: 9781640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to Coss-86 neoadjuvant therapy assessed by computed tomography and histology.
    Liszka G; Szendröi M; Szántó J
    Acta Chir Hung; 1992-1993; 33(1-2):109-16. PubMed ID: 1343453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
    Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
    Pathol Res Pract; 1998; 194(10):679-84. PubMed ID: 9820863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological characterization of human bone tumors. IV. Combined biochemical and histological analyses of different osteosarcomas.
    Althoff J; Quint P; Höhling HJ; Roessner A; Grundmann E
    Pathol Res Pract; 1985 Oct; 180(4):383-91. PubMed ID: 3865164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of the degree of morphological regression following chemotherapy in malignant bone tumors].
    Salzer-Kuntschik M; Brand G; Delling G
    Pathologe; 1983 May; 4(3):135-41. PubMed ID: 6576329
    [No Abstract]   [Full Text] [Related]  

  • 18. Differentiating and antitumor activities of 1 alpha,25-dihydroxyvitamin D3 in vitro and 1 alpha-hydroxyvitamin D3 in vivo on human osteosarcoma.
    Tsuchiya H; Morishita H; Tomita K; Ueda Y; Tanaka M
    J Orthop Res; 1993 Jan; 11(1):122-30. PubMed ID: 8423514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic response of various histological osteosarcoma subtypes to high-dose methotrexate treatment].
    Schulz A; Fischer HP; Breithaupt H; Pralle H
    Onkologie; 1983 Dec; 6(6):296-304. PubMed ID: 6366675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16 expression predicts neoadjuvant tumor necrosis in osteosarcomas: reappraisal with a larger series using whole sections.
    Kosemehmetoglu K; Ardic F; Karslioglu Y; Kandemir O; Ozcan A
    Hum Pathol; 2016 Apr; 50():170-5. PubMed ID: 26997452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.